2024 annual financial data
Protagonist Therapeutics 2024 Operating margin
Protagonist Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was 58.2%.
Operating income was 252,843,000 USD and net income was 275,188,000 USD.
Operating cash flow was 184,152,000 USD.
Get free Protagonist Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 434,433,000 USD
- Operating income
- 252,843,000 USD
- Net income
- 275,188,000 USD
- Operating cash flow
- 184,152,000 USD